Concepedia

Michael Boice

MB

Statistics

Publications

6

Citations

550

H-Index

6

Active since

2012

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Ghent University Hospital

Ghent University

Inserm

Michael Boice is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, molecular oncology, and tumor suppressor genes.

Publications per year

2012–2016

6

Publications

6

Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells

Michael Boice, Darin Salloum, Frédéric Mourcin et al. · Cell · 2016 · 243 citations · Full text

, , +14

MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia

Evelien Mets, Joni Van der Meulen, Gert Van Peer et al. · Leukemia · 2014 · 110 citations

, , +17

MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia

Evelien Mets, Gert Van Peer, Joni Van der Meulen et al. · Haematologica · 2014 · 71 citations · Full text

, , +17

A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers

Amanda F. Baker, K. N. Adab, Natarajan Raghunand et al. · Investigational New Drugs · 2012 · 52 citations

, , +11

Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia

Viraj R. Sanghvi, Konstantinos J. Mavrakis, Joni Van der Meulen et al. · Science Signaling · 2014 · 41 citations

, , +15

1–5 of 6